Kathleen M. Schmeler MD
Gynecologic Oncology
Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine - University of Texas MD Anderson Cancer Center.
Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Schmeler is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2004 - 2007
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2000 - 2004
Drexel University College of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
OK State Medical License 2020 - 2027
TN State Medical License 2023 - 2027
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Laparoscopic Approach to Cervical Cancer
- Pelvic Fractures and Radiation Therapy for Cervical Cancer Start of enrollment: 2008 Nov 05
- Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer Start of enrollment: 2010 Apr 15
Publications & Presentations
PubMed
- Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial.Jeffrey A How, Shannon N Westin, Melissa Pham, Barrett Lawson, Minxing Chen
Nature Communications. 2026-09-01 - Patient navigation as a core component of global cancer care-A call to action from the Global Alliance for Cancer Patient Navigation.Anurag K Agrawal, Kristie McComb, Carla Thamm, Nirmala Bhoo-Pathy, Dylan Graetz
Cancer. 2026-08-15 - Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health sys...Graciela M Nogueras Gonzalez, Trisha L Amboree, Susan Parker, Shaun Bulsara, Ashish Deshmukh
Gynecologic Oncology. 2026-08-01
Journal Articles
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerShannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology
Other
- Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)Schmeler KM, Lu KH
http://www.uptodate.com/contents/endometrial-and-ovarian-cancer-screening-and-prevention-in-women-wi
UpToDate, Wolters Kluwer Health - 2012-11-12
Authored Content
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Press Mentions
Secretary Kennedy’s Dangerous Disservice: Gardasil FalsehoodsApril 30th, 2025- Physicians Applaud New HPV Testing Guidance, Support Self-CollectionDecember 23rd, 2024
- How MD Anderson Uses Teleconsulting to Tackle Care GapsNovember 20th, 2024
Grant Support
- Training of Academic Gynecologic OncologistsUNIVERSITY OF TX MD ANDERSON CAN CTR2005–2031
- The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIVUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in MozambiqueUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2027
- Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancerRICE UNIVERSITY2020–2025
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
